Lv5
808 积分 2023-07-18 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1天前
待确认
The 2023 Annual Report of DataDerm: The database of the American Academy of Dermatology
3天前
已完结
Diagnosis and treatment of acne inversa/hidradenitis suppurativa in China: an expert consensus statement （2021 version）
3天前
已完结
司库奇尤单抗在强直性脊柱炎治疗中的研究进展
7天前
已完结
Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-α use in females with immune mediated diseases; a systematic review and meta-analysis
7天前
已完结
强直性脊柱炎的诊断与治疗骨科专家共识
7天前
已完结
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
8天前
已完结
司库奇尤单抗在强直性脊柱炎治疗中的研究进展
8天前
已关闭
Expert consensus on treat-to-target approach for the treatment of psoriasis with biological agents
8天前
已完结
5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial
9天前
已完结
皖公网安备34019202002308
